Gunnar Juliusson

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Gunnar Juliusson, Petar Antunović, Åsa Rangert Derolf et al. · Blood · 2008 · 987 citations

Medicine, Hematology, Oncology +16

Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities

Gunnar Juliusson, David Oscier, M Fitchett et al. · New England Journal of Medicine · 1990 · 609 citations

Medicine, Hematology, Oncology +13

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

The French Cooperative Group on CLL, S.A. Johnson, Alex Smith et al. · The Lancet · 1996 · 438 citations

Medicine, Immunology, Oncology +10

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Sören Lehmann, Vladimir J.N. Bykov, Dina Ali et al. · Journal of Clinical Oncology · 2012 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Mark J. Levis, Farhad Ravandi, Eunice S. Wang et al. · Blood · 2011 · 399 citations · Full text

Medicine, Oncology, Pharmacotherapy +14